论文部分内容阅读
近年来,随着血管介入治疗在妇科的应用和新辅助化疗(NACT)的提出,中晚期宫颈癌患者的生存率较90年代初大大提高。NACT可缩小局部病灶,降低肿瘤的分期,为根治手术创造条件,而且可提高放射治疗的局部控制率[1]。但NACT的方案和方式较多,笔者对在我院术前接受DSA下动脉介入化疗的1
In recent years, with the application of vascular interventional therapy in gynecology and neoadjuvant chemotherapy (NACT), the survival rate of patients with advanced cervical cancer is much higher than that of the early 1990s. NACT can reduce the local lesion, reduce tumor staging, to create conditions for radical surgery, but also to improve the local control of radiation therapy [1]. However, NACT’s programs and methods are more, the author of our hospital under the preoperative DSA artery interventional chemotherapy 1